Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial

Table 3 Dietary intake and Physical Activity changes

Measurements	NAOs group (n = 42)			Placebo group (n = 42)			p-value²⁾
Measurements	Baseline	16 week	p-value¹⁾	Baseline	16 week	p-value¹⁾	p-value²⁾
Energy (kcal)	1437.869 ± 501.638	1413.147 ± 493.146	0.725	1393.406 ± 323.663	1405.211 ± 284.334	0.810	0.669
Carbohydrates (g)	199.292 ± 60.685	196.488 ± 68.177	0.791	194.786 ± 53.173	194.846 ± 40.550	0.995	0.837
Lipids (g)	45.363 ± 31.584	43.578 ± 25.586	0.538	42.155 ± 16.131	43.957 ± 14.856	0.437	0.332
Protein (g)	55.972 ± 20.505	57.616 ± 24.497	0.572	57.354 ± 14.531	56.459 ± 16.431	0.725	0.510
Fiber (g)	14.119 ± 8.151	13.423 ± 5.880	0.389	14.466 ± 6.002	15.193 ± 6.250	0.417	0.237
MET (min/week)	1748.190 ± 4727.484	1037.143 ± 2003.833	0.188	1223.810 ± 1805.402	1051.429 ± 2721.270	0.722	0.454

NAOs, Neoagaro-oligosaccharides
Values are presented as the mean ± SD
¹⁾ Analyzed by paired t-test between baseline and 16 weeks within each group (Weeks 0 vs. 16)
²⁾ Analyzed by independent t-test for change value between the groups (NAOs vs. Placebo)

ISSN: 2662-7671